Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pavmed Inc (PAVM)

Pavmed Inc (PAVM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 98,011
  • Shares Outstanding, K 47,463
  • Annual Sales, $ 0 K
  • Annual Income, $ -16,460 K
  • 60-Month Beta -0.03
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +475,814.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.91 +8.12%
on 07/31/20
2.23 -7.61%
on 07/21/20
-0.01 (-0.72%)
since 07/07/20
3-Month
1.90 +8.68%
on 06/11/20
2.82 -26.77%
on 05/21/20
-0.35 (-14.32%)
since 05/07/20
52-Week
0.81 +154.94%
on 11/14/19
3.45 -40.14%
on 02/25/20
+1.06 (+104.46%)
since 08/07/19

Most Recent Stories

More News
PAVmed Secures $7 Million Convertible Note Financing

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the "Company" or "PAVmed"), a highly differentiated, multi-product, commercial-stage medical device company, today announced it has received approximately $7 million...

PAVM : 2.06 (+1.48%)
PAVmed to Hold Business Update Conference Call on August 18, 2020

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the "Company" or "PAVmed"), a highly differentiated, multi-product, commercial-stage medical device company, today announced that the Company will host a business update...

PAVM : 2.06 (+1.48%)
PAVmed to Present at Maxim Group's COVID-19 Webinar on July 16, 2020

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the "Company" or "PAVmed"), a highly differentiated, multi-product, commercial-stage medical device company, today announced that Shaun O'Neil, Chief Commercial Officer...

PAVM : 2.06 (+1.48%)
PAVmed to Join the Russell 2000(R) and Russell 3000(R) Indexes

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the "Company" or "PAVmed"), a highly differentiated, multiproduct medical device company, today announced the Company is set to join the small-cap Russell 2000 Index...

PAVM : 2.06 (+1.48%)
Founder and Former Chairman & CEO of Exact Sciences Stanley Lapidus Joins PAVmed Subsidiary Lucid Diagnostics as Strategic Advisor

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the "Company" or "PAVmed"), a highly differentiated, multiproduct medical device company, today announced that medical diagnostics pioneer Stanley Lapidus, founder and...

PAVM : 2.06 (+1.48%)
EXAS : 86.69 (-4.10%)
ContraFect Announces Appointment of Lishan Aklog, M.D. to Board of Directors

ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical...

CFRX : 5.54 (+0.54%)
PAVM : 2.06 (+1.48%)
PAVmed Subsidiary Lucid Diagnostics Receives Preliminary Payment Determination for EsoGuard(TM) Esophageal DNA Test

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the "Company" or "PAVmed"), a highly differentiated, multiproduct medical device company, today announced that its majority owned subsidiary, Lucid Diagnostics Inc. ("Lucid"),...

PAVM : 2.06 (+1.48%)
PAVmed Collaborates with Canon on DisappEAR(TM) Pediatric Ear Tubes

Executed LOI with Canon Virginia, Inc. to develop and implement commercial grade processes to manufacture molded resorbable pediatric ear tubes from aqueous silk fibroin

CAJ : 17.14 (+1.84%)
PAVM : 2.06 (+1.48%)
PAVmed Reports Preliminary First Quarter 2020 Financial Results and Provides Business Update

Conference call to be held today at 4:30 p.m. Eastern time

PAVM : 2.06 (+1.48%)
PAVmed to Hold Business Update Conference Call on May 21, 2020

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the "Company" or "PAVmed"), a highly differentiated, multiproduct medical device company, today announced that the Company will host a business update conference call...

PAVM : 2.06 (+1.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade PAVM with:

Business Summary

PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat carpal tunnel syndrome; NextFlo(TM) and NextCath(TM) a disposable infusion pump; PortIO(TM) and NextCath interventional radiology and Caldus (TM) tissue ablation...

See More

Key Turning Points

2nd Resistance Point 2.15
1st Resistance Point 2.11
Last Price 2.06
1st Support Level 2.01
2nd Support Level 1.95

See More

52-Week High 3.45
Fibonacci 61.8% 2.44
Fibonacci 50% 2.13
Last Price 2.06
Fibonacci 38.2% 1.82
52-Week Low 0.81

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar